Annual report [Section 13 and 15(d), not S-K Item 405]

Consolidated Balance Sheets

v3.25.4
Consolidated Balance Sheets - USD ($)
$ in Millions
Dec. 31, 2025
Dec. 31, 2024
Current assets:    
Cash and cash equivalents $ 353.1 $ 415.3
Receivables, net of allowance for doubtful accounts 91.9 68.9
Inventories 511.7 475.4
Prepaid expenses and other current assets 188.0 184.1
Total current assets 1,144.7 1,143.7
Property, plant, and equipment, at cost, net of accumulated depreciation and amortization 447.7 460.2
Operating lease right-of-use assets 168.3 185.7
Marketing-related intangibles and other intangible assets, net 315.1 312.3
Goodwill 100.5 87.7
Deferred income tax assets 464.3 398.6
Other assets 145.3 139.9
Total assets 2,785.9 2,728.1
Current liabilities:    
Accounts payable 99.8 70.0
Member compensation liabilities 402.4 359.9
Current portion of long-term debt 20.9 283.5
Other current liabilities 489.8 517.0
Total current liabilities 1,012.9 1,230.4
Long-term debt, net of current portion 1,971.7 1,976.6
Non-current operating lease liabilities 155.7 169.5
Other non-current liabilities 155.0 152.7
Total liabilities 3,295.3 3,529.2
Commitments and contingencies
Shareholders' deficit:    
Common shares, $0.0005 par value; 2.0 billion shares authorized; 103.3 million (2025) and 101.2 million (2024) shares outstanding 0.1 0.1
Paid-in capital in excess of par value 316.0 278.2
Accumulated other comprehensive loss (251.5) (271.4)
Accumulated deficit (579.7) (808.0)
Total Herbalife shareholders' deficit (515.1) (801.1)
Noncontrolling interest 5.7 0.0
Total shareholders' deficit (509.4) (801.1)
Total liabilities and shareholders' deficit $ 2,785.9 $ 2,728.1